Walking the 3rd Saturday of every month @ 11AM
UNC Wellness Center at Meadowmont: 100 Sprunt Street, Chapel Hill, NC 27517
The goal of this project is to explore the feasibility of a walking exercise program to improve mobility and quality of life for people suffering from Systemic Lupus Erythematosus (SLE). This program is based on a similar and effective program focusing on individuals with arthritis. The proposed intervention is highly translational, and if proven to be effective, could go into practice relatively quickly.
NC TraCS is the academic home of the NIH Clinical and Translational Science Award (CTSA).
Check out the full newsletter and acknowledgement with this link;
Dr. Beth Jonas, our Program Director for the Rheumatology Fellowship, founding member of the Carolina Fellows Collaborative, and 2014 awardee of the ACR’s Clinician Scholar Educator Award, will be awarded the 2015 Distinguished Fellowship Program Director Award. This Award of Distinction will be presented during the Opening Ceremonies.
Drs. Jordan, Callahan, and Loeser awarded 5 year, $6.7 million grant from NIAMS for a pragmatic clinical trial of Weight loss and Exercise for Communities with Arthritis in North Carolina (“WE-CAN”)
Drs. Jordan, Callahan, and Loeser awarded 5 year, $6.7 million grant from NIAMS for a pragmatic clinical trial of Weight loss and Exercise for Communities with Arthritis in North Carolina (“WE-CAN”).
NIH’s National Institute of Arthritis and Musculoskeletal and Skin Diseases announced that UNC will be part of a multi-center U01 study including Wake Forest University and Brigham and Women’s Hospital and will receive a 5 year, $6.7 million dollar grant, beginning September 1, 2015. The research study, “Weight loss and exercise for communities with arthritis in North Carolina (WE-CAN),” will implement and test the effectiveness and cost-effectiveness of an evidence-based practical, diet-induced weight loss and exercise intervention that communities can implement to reduce pain and improve other clinical outcomes in people with knee osteoarthritis (OA).
Joanne M. Jordan, MD, MPH, Joseph P. Archie Eminent Professor of Medicine, Director of the Thurston Arthritis Research Center and Chief, Division of Rheumatology, Allergy and Immunology at UNC is the Co-Principal Investigator with Dr. Stephen Messier of Wake Forest University. The UNC site leader and Co-Investigator is Leigh Callahan, PhD, Mary Link Briggs Distinguished Professor of Medicine, Director of Epidemiology and Outcomes Research at the Thurston Arthritis Research Center and Director of the Osteoarthritis Action Alliance. Richard Loeser, MD, Herman and Louise Smith Distinguished Professor of Medicine and Director of Basic and Translational Science at Thurston is co-investigator. Adjunct Professor of Medicine Kate T. Queen, MD, will lead the effort in Haywood County.
Drs. Jordan, Callahan, Loeser, and Queen will supervise and execute a diet and exercise intervention program, working closely with community partners in Johnston and Haywood counties. Their goals will be to determine whether an evidence-based diet and moderate exercise intervention can be implemented successfully in community-based settings in North Carolina with diverse residential (from urban to rural) and socioeconomic patterns to decrease knee pain in overweight and obese adults with knee OA, relative to a physician advice comparator group. The study will also ascertain the cost-effectiveness of the pragmatic community-based multimodal program, and conduct a budgetary impact analysis to facilitate implementation of such a program in community settings across the United States.
In addition to the Exceptional Patient Service Award, our Allergy/Immunology Clinic was also presented with the "The Good Guy Award" for exceptional courtesy based on having the highest score over all the clinics in nursing, business staff, physician and team work categories. Please join us in celebrating their amazing hard work and dedication to our patients!
Osteoarthritis (OA) is a leading cause of pain and disability among adults in general, but African Americans experience a disproportionate burden, including greater prevalence and more severe symptoms and functional limitations. Emerging data suggest that pain Coping Skills Training (CST) programs may help to reduce racial disparities in OA symptom severity. A new study, led by Dr. Kelli Allen and her research team at the Thurston Arthritis Research Center, will evaluate the effectiveness of a culturally enhanced pain CST program among African Americans with OA.
This three-year project is funded by the Patient-Centered Outcomes Research Institute and involves collaborations with investigators at Duke University Medical Center, the Durham VA Medical Center, and East Carolina University. The study will involve 248 African Americans with symptomatic hip or knee OA. Half of the study participants will be patients within the UNC healthcare system and half will be patients at the Durham VA Medical Center. This randomized controlled trial will test a 12-session, telephone-based pain CST program that is based on previous studies but enhanced through input from African Americans with OA and other stakeholders involved in the study.
Portsia Latta, NA, with the UNC Rheumatology Clinic, received a Plus People Award from UNC Healthcare. This honor is presented to UNC Healthcare employees for their outstanding performance and service. The Plus People Awards were established to recognize those who exemplify the characteristics of one or more of the pillars of Commitment to Caring. The award is a tribute to the positive attitude she brings to her job, the high quality of her work and her concern for all the people she serves. Ms. Latta has been a member of the UNC Rheumatology Clinic Nursing Team for four years and enjoys “interacting with patients and their families.”
Dr. Loeser’s team seeks to define the role of the gut microbiome in the pathogenesis of osteoarthritis (OA). OA is the most common form of arthritis, affecting over 27 million Americans, and is the #1 cause of chronic disability in adults. Management of OA is limited by the lack of interventions that slow disease progression. A better mechanistic understanding of OA is needed to develop new interventions that target mechanisms driving the disease process. Mounting evidence suggests that metabolic alterations, a systemic low grade pro-inflammatory state, and activation of the innate immune system play key roles in OA. These same factors have also been associated with altered composition of the gut microbiota (dysbiosis), which in turn is influenced by diet, in particular a high fat diet that contributes to obesity. We propose that dysbiosis of the gut microbiota, by promoting a chronic systemic pro-inflammatory state, can accelerate or worsen the development of OA when other risk factors, such as obesity or joint injury, are also present.
The unique multidisciplinary team of outstanding investigators will test the hypothesis that components of the gut microbiome contribute to the development of OA through activating innate immunity and promoting an inflammatory state. The success of these novel studies will have major public health implications. Defining a contribution of the gut microbiome to OA would indicate the use of microbiota profiling as a novel approach to identify individuals at risk of progressive OA and aid in the design of novel dietary, antibiotic, probiotic or prebiotic interventions to alter the specific components of the microbiome that contribute to OA progression.
In submitting publications, presentations and grant applications using data from your Phase I award, please remember to acknowledge the SOM Office of Research and TraCS Translational Team Science Award.